Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T
- PMID: 17190841
- PMCID: PMC2118430
- DOI: 10.1084/jem.20062409
Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T
Abstract
Somatic hypermutation (SHM) introduces nucleotide substitutions into immunoglobulin variable (Ig V) region genes at all four bases, but the mutations at C/G and A/T pairs are achieved by distinct mechanisms. Mutations at C/G pairs are a direct consequence of the C-->U deamination catalyzed by activation-induced deaminase (AID). Mutations at A/T pairs, however, require a second mutagenic process that occurs during patch repair of the AID-generated U/G mismatch. Several DNA polymerases have been proposed to play a role in SHM, but accumulating evidence indicates that the mutations at A/T are overwhelmingly achieved by recruitment of DNA polymerase eta.
Figures

Comment on
-
DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse.J Exp Med. 2007 Jan 22;204(1):17-23. doi: 10.1084/jem.20062131. Epub 2006 Dec 26. J Exp Med. 2007. PMID: 17190840 Free PMC article.
Similar articles
-
An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.Trends Immunol. 2005 Apr;26(4):215-20. doi: 10.1016/j.it.2005.02.008. Trends Immunol. 2005. PMID: 15797512 Review.
-
Reflections on the state of play in somatic hypermutation.Mol Immunol. 2008 May;45(10):2723-6. doi: 10.1016/j.molimm.2008.02.002. Epub 2008 Mar 21. Mol Immunol. 2008. PMID: 18359085
-
Mutating for Good: DNA Damage Responses During Somatic Hypermutation.Front Immunol. 2019 Mar 12;10:438. doi: 10.3389/fimmu.2019.00438. eCollection 2019. Front Immunol. 2019. PMID: 30915081 Free PMC article. Review.
-
Competitive repair pathways in immunoglobulin gene hypermutation.Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):613-9. doi: 10.1098/rstb.2008.0206. Philos Trans R Soc Lond B Biol Sci. 2009. PMID: 19010770 Free PMC article. Review.
-
RNA-directed DNA repair and antibody somatic hypermutation.Trends Genet. 2022 May;38(5):426-436. doi: 10.1016/j.tig.2021.10.005. Epub 2021 Nov 2. Trends Genet. 2022. PMID: 34740453 Review.
Cited by
-
Does DNA repair occur during somatic hypermutation?Semin Immunol. 2012 Aug;24(4):287-92. doi: 10.1016/j.smim.2012.05.002. Epub 2012 Jun 22. Semin Immunol. 2012. PMID: 22728014 Free PMC article. Review.
-
Ectopic expression of AID in a non-B cell line triggers A:T and G:C point mutations in non-replicating episomal vectors.PLoS One. 2008 Jan 23;3(1):e1480. doi: 10.1371/journal.pone.0001480. PLoS One. 2008. PMID: 18213388 Free PMC article.
-
Mutagenesis dependent upon the combination of activation-induced deaminase expression and a double-strand break.Mol Immunol. 2010 Nov-Dec;48(1-3):164-70. doi: 10.1016/j.molimm.2010.08.013. Epub 2010 Sep 9. Mol Immunol. 2010. PMID: 20828826 Free PMC article.
-
Signaling control of antibody isotype switching.Adv Immunol. 2019;141:105-164. doi: 10.1016/bs.ai.2019.01.001. Epub 2019 Feb 11. Adv Immunol. 2019. PMID: 30904131 Free PMC article. Review.
-
Nucleotide Weight Matrices Reveal Ubiquitous Mutational Footprints of AID/APOBEC Deaminases in Human Cancer Genomes.Cancers (Basel). 2019 Feb 12;11(2):211. doi: 10.3390/cancers11020211. Cancers (Basel). 2019. PMID: 30759888 Free PMC article.
References
-
- Muramatsu M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553–563. - PubMed
-
- Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 102:565–575. - PubMed
-
- Rada, C., M.R. Ehrenstein, M.S. Neuberger, and C. Milstein. 1998. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity. 9:135–141. - PubMed
-
- Zeng, X., D.B. Winter, C. Kasmer, K.H. Kraemer, A.R. Lehmann, and P.J. Gearhart. 2001. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol. 2:537–541. - PubMed